Annual report pursuant to Section 13 and 15(d)

Note 26 - Concentrations

v3.24.1.u1
Note 26 - Concentrations
12 Months Ended
Dec. 31, 2023
Notes to Financial Statements  
Concentration Risk Disclosure [Text Block]

Note 26. Concentrations

 

e-Commerce operations concentrations:

 

Customers:

 

Amazon accounted for 51.6% and 54.3% of the Company’s revenues during the years ended December 31, 2023 and 2022, respectively. No other customer accounted for 10% or more of the Company’s revenues for either period.

 

Suppliers:

 

The following table sets forth information as to each supplier that accounted for 10% or more of the Company’s purchases for the years ended December 31, 2023 and 2022 (in thousands):

 

   

December 31, 2023

   

December 31, 2022

 
                                 

Garmin

  $ 1,921       22.4 %   $ 1,821       20.9 %

Globalstar Europe

  $ 958       11.2 %   $ 635       7.3 %

Network Innovations

  $ 935       10.7 %   $ 980       11.2 %

Iridium Satellite

  $ 913       10.9 %   $ -       - %

Satcom Global

  $ 761       8.9 %   $ 744       8.5 %

 

Geographic:

 

The following table sets forth revenue as to each geographic location, for the years ended December 31, 2023 and 2022(in thousands):

 

   

Year Ended

           

Year Ended

         
   

December 31, 2023

           

December 31, 2022

         
                                 

Europe

  $ 6,687       60.9 %   $ 8,617       73.7 %

North America

    2,575       23.4 %     2,152       18.3 %

South America

    62       0.6 %     45       0.4 %

Asia and Pacific

    1,510       13.8 %     760       6.5 %

Africa

    143       1.3 %     136       1.1 %
    $ 10,977       100.0 %   $ 11,710       100.0 %

 

Healthcare operations concentrations:

 

Suppliers:

 

      Progressive Care had significant concentrations with one vendor. The purchases from this significant vendor were approximately 99.0% of total vendor purchases for the six months ended December 31, 2023.

 

Customers:

 

Progressive Care s trade receivables are primarily from prescription medications billed to various insurance providers. Ultimately, the insured is responsible for payment should the insurance company not reimburse Progressive Care.

 

Progressive Care generated reimbursements from three significant PBMs for the six months ended December 31, 2023:

 

   

2023

 

A

    31 %

B

    29 %

C

    14 %